Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Infra Updates
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | H1₹6.84Admitted-Finance SURVEY NO 144 A JAROD SAMLAYA ROAD VILL HARIPURA TAL SAVLI DIST VADODARA GUJARAT INDIA 391520 | VADODARA | VADODARA | GUJARAT | 391520 | H1 | Admitted-Finance | |
| 2 | H2₹6.37−₹0.47 (6.87%)Admitted-Finance | H2 | Admitted-Finance | |
| 3 | H3₹6.27−₹0.57 (8.33%)Admitted-Finance NO 32 11 2 34 1 TO 4 7TH TO 12TH FLOOR PRESTIGE PLATINA BLOCK 3 KADUBEESANAHALLI VILLAGE VARTHUR HOBLI OUTER RING ROAD BANGALORE 560 103 | BANGALORE | BANGALORE | KARNATAKA | 560103 | H3 | Admitted-Finance | |
| 4 | H4₹5.92−₹0.92 (13.5%)Admitted-Finance HETERO CORPORATE 7 2 A2 INDUSTRIAL ESTATE SANATH NAGAR HYDERABAD 500018 | HYDERABAD | HYDERABAD | TELANGANA | 500018 | H4 | Admitted-Finance | |
| 5 | Not Admitted-Fee/PreQual/Technical | - | Not Admitted-Fee/PreQual/Technical Others-Bidder is debarred and blacklisted by CMSS on 29/07/2024 to participate in future tender of CMSS. Hence, the bid of M/s Centurion Laboratories Pvt Ltd is not accepted and summarily rejected at this stage in compliance with tender clause no. 4 (f). |
| Sl No | Description | Qty | Unit | MYLAN LABORATORIES LIMITED H3 | HETERO LABS LIMITED H4 | Laurus Labs Limited H2 | Bharat Parenterals Ltd. H1 |
|---|---|---|---|---|---|---|---|
| 1.00ANTI TB DRUGS | |||||||
| 1.01 | Tenofovir 300mg+ Lamivudine 300mg+ Dolutegravir 50mg (TLD) | 38,00,65,364 | Tablets | 5.6 ₹6.27 | 5.29 ₹5.92 Lowest | 5.69 ₹6.37 | 6.11 ₹6.84 |
Tender Value
Refer Docs
EMD Value
₹5.4 Cr
Closing Date
1 Aug 2024, 3:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
DG and CEO CMSS
CMSS New Delhi
Online Risk Purchase Tender for Procurement and Supply of Tenofovir 300mg Lamivudine 300mg Dolutegravir 50mg (TLD) For NACO
2024_CMSS_815568_1
CMSS/PROC/2024-25/NACO/015
Open Tender
Drugs and Pharmaceutical Products
Fixed-rate
90 days
CMSS New Delhi
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹5.4 Cr
Yes
CMSS New Delhi
16 Oct 2024
9 Jul 2024
2 Aug 2024
9 Jul 2024
1 Aug 2024
16 Jul 2024
9 Jul 2024 - 12 Jul 2024
12 Jul 2024
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1ANTI TB DRUGS | |||||
| 1.01 | Tenofovir 300mg+ Lamivudine 300mg+ Dolutegravir 50mg (TLD) | 38,00,65,364 | Tablets | - | - |
stage.html
html • 0.04 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
BOQ_857092.xls
BOQ Document • 0.27 MB
147861225.pdf
Tender Document • 2.52 MB
TED015.pdf
Tender Document • 2.50 MB
147861228.html
Tender Document • 0.05 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .